Alpine Associates Management’s NxStage Medical Inc. NXTM Stock Holding History

Alpine Associates Management’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,433,167	Closed	-$69.6M	–	61
2018 Q4	$69.6M	Sell	2,433,167 -590,504	-20%	-$16.8M	2.9%	14
2018 Q3	$84.3M	Sell	3,023,671 -303,311	-9%	-$8.53M	2.32%	19
2018 Q2	$93.1M	Buy	3,326,982 +30,300	+0.9%	+$812K	2.89%	14
2018 Q1	$82M	Sell	3,296,682 -738,555	-18%	-$18M	2.7%	15
2017 Q4	$97.8M	Buy	4,035,237 +43,779	+1%	+$1.15M	3.5%	9
2017 Q3	$110M	Buy	+3,991,458	New	+$106M	3.72%	8

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Alpine Associates Management's NXTM Position: Q1 2019 in Review

Alpine Associates Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 2,433,167 shares — an estimated $69.6M sold.

Alpine Associates Management first reported a position in NXTM in Q3 2017 and held it in 6 quarters. The position peaked at $110M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Alpine Associates Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Alpine Associates Management sold 2,433,167 NxStage Medical Inc. shares in Q1 2019, an estimated $69.6M.
Alpine Associates Management first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 6 quarters.
Alpine Associates Management's NxStage Medical Inc. position peaked at $110M in Q3 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Alpine Associates Management's 13F filing for Q1 2019, filed 9 May 2019.